Global Therapeutic Laser Market - Forecasts from 2024 to 2029

Global Therapeutic Laser Market - Forecasts from 2024 to 2029

The global therapeutic laser market is expected to grow at a CAGR of 9.47% over the forecast period to reach a total market size of US$237.022 billion by 2029, increasing from US$125.805 billion in 2022.

A therapeutic laser system is a drug-free, non-invasive therapy approach that relieves chronic and acute pain while also improving blood circulation. These devices employ laser pulses that penetrate through the skin without creating warmth, injury, or other negative effects. The therapeutic laser system speeds up wound healing and lowers soft tissue inflammation and discomfort. This laser therapy is viewed as an alternative, if not a supplement, to standard medication and surgical treatment. These laser systems include a long-term therapeutic effect by addressing the fundamental causes of illness disorders.

Therapeutic lasers, also known as low-level lasers or cold lasers, are medical devices that use low-level light to stimulate cellular function and promote healing. They are used in various medical and healthcare applications for pain management, wound healing, and tissue repair. The market includes different types of therapeutic lasers, such as diode lasers, dye lasers, and CO2 lasers. Therapeutic lasers are widely used for pain relief, wound healing, dermatology, and dentistry. Key players in the market include established medical device companies and emerging players.

Regulatory approvals from health authorities like the FDA and EMA are essential for market entry. Restraints include limited awareness among healthcare providers and patients about therapeutic lasers' benefits and reimbursement issues. Future trends include integration with other technologies, home-use devices, and ongoing research and clinical trials. The global therapeutic laser market is expected to expand globally due to increased awareness, technological advancements, and growing demand for non-invasive therapeutic options.

Market Drivers:

Increased cancer incidences are anticipated to propel the demand for therapeutic lasers globally.

The need for a therapeutic laser is increasing due to rising cancer occurrences globally, an increase in the number of operations, and increased awareness of self-care and self-management. Furthermore, increased disposable income, rising healthcare spending, and shorter hospital stays would drive the worldwide therapeutic laser market in the projected decade and beyond.

Moreover, several companies have taken the initiative to launch new innovative products that have propelled the market to grow during the projected period. For instance, Theralase Technology, a Canadian producer of patent laser technologies in both the Anti-Cancer Therapy (ACT) and Medical Laser Technology (MLT) sectors, intends to introduce new, breakthrough pain and cancer solutions in 2021. They've also shown that their primary PDC can eliminate several viruses, including H1N1 flu and Zika.

North America region is expected to witness a surge in its global market share.

North America has been a major market for therapeutic lasers until now and is expected to surge in its global market share. This can be attributed to the growing prevalence of demand for cosmetic surgeries across several countries in this region. Primary cosmetic treatments for veins, skin resurfacing, and hair removal using laser therapy have increased significantly in the region. For instance, according to the American Society of Plastic Surgeons annual report, it was reported that 168,682 laser treatments for veins, 997,245 laser skin resurfacing, and 757,808 laser removal procedures were performed in 2020. Thus, these extensive medical applications and the wide adoption of these procedures have propelled the demand for the therapeutic lasers market in the region.

Further, the growing demand for these lasers can also be attributed to an increase in the provision of patents in the region. For instance, in July 2021, Aspen Laser LLC, which is a major medical solutions company, was awarded a new patent by the USPTO (U.S. Patent and Trademark Office). The patent was reported to cover particular laser devices that would be manufactured by the company and sold in the veterinary and medical markets.

Furthermore, major companies in the region have been focused on the implementation of strategic initiatives, such as mergers, collaborative agreements, and acquisitions, for the consolidation of their position in the market. For instance, in September 2021, Boston Scientific completed the acquisition of the worldwide surgical business of Lumenis LTD, an energy-based medical solutions company, from an affiliate of BPEA (Baring Private Equity Asia). The surgical business of Lumenis comprised of fibers, premier laser systems, and accessories that are deployed in the otolaryngology and urology procedures. Thus, developments like these are further expected to propel the market growth.

Market Key Developments:

June 2023- BioLASE, a global leader in dental lasers, partnered with Pet Dental Services (PDS), the top non-anesthetic pet dental provider in the country, to integrate BIOLASE's diode laser technology. PDS aims to gain the trust and confidence of veterinarians across the country, providing service through veterinary hospitals. PDS has an excellent reputation among a network of over 300 veterinarians. BioLASE's diode laser technology not only treats periodontal disease but also helps pets live healthier lives BioLASE's proprietary laser products incorporate approximately 266 patented and 25 patent-pending technologies, providing biologically and clinically superior performance with less pain and faster recovery times.
April 2023- Lumibird Medical launched two new next-generation Nd:YAG/SLT lasers, the Tango™ Neo and Ultra Q™ Reflex Neo, by Ellex®. The Tango Reflex™ Neo is a fully integrated Q-switched Nd:YAG laser for anterior-segment YAG and glaucoma indications, featuring second-generation Reflex™ technology with True Coaxial Illumination (TCI™). It also includes Imprint™, a dynamic heads-up display, joystick control of energy settings, and up to 2 mm YAG posterior offset for PROcap™ – Premium Refractive Outcome Capsulotomies. The Tango™ Neo has an improved general user interface with a modern look and feel. The lasers are CE-marked and USA FDA 510K approved.
April 2023- Topcon Corporation partnered with Espansione Group to distribute their light-based technologies in the Southeast Asian region. The partnership allows Topcon to access innovative treatment products like Light Modulation® Low-level Light Therapy (LM® LLLT), photobiomodulation technology, and Optimal Power Energy® Intense Pulsed Light (OPE® IPL). This strategic alliance enables Espansione to push the boundaries of ophthalmology in APAC and SEA. Topcon's service spectrum expand, offering comprehensive solutions from pre-diagnosis to effective dry eye treatment and post-treatment follow-ups.

Market Segmentation:

By Therapy
Carbon Dioxide Laser
YAG (yttrium aluminum garnet) Laser
Pulsed Dye Laser
Argon Laser
Low-level laser therapy (LLLT)
By Application
LASIK or Laser Eye Surgery
Teeth Whitening
Cosmetic Scar, Tattoo or Wrinkle Removal
Tumor Removal
Others
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
Japan
South Korea
India
Thailand
Others